Ra Capital Management, Llc
Affiliations
- at 4D Molecular Therapeutics Inc. (FDMT), 2024-12-10
- at Cidara Therapeutics Inc. (CDTX), 2024-11-29
- at 89Bio Inc. (ETNB), 2024-11-19
- at Tyra Biosciences Inc. (TYRA), 2024-11-13
- at Septerna Inc. (SEPN), 2024-10-30
- at Janux Therapeutics Inc. (JANX), 2024-10-22
- at Fulcrum Therapeutics Inc. (FULC), 2024-09-23
- at Bicara Therapeutics Inc. (BCAX), 2024-09-18
- at Wave Life Sciences Ltd. (WVE), 2024-08-14
- at An2 Therapeutics Inc. (ANTX), 2024-08-13
- at Artiva Biotherapeutics Inc. (ARTV), 2024-07-24
- at Eliem Therapeutics Inc. (ELYM), 2024-07-02
- at Acrivon Therapeutics Inc. (ACRV), 2024-06-24
- at Ars Pharmaceuticals Inc. (SPRY), 2024-06-24
- at Pepgen Inc. (PEPG), 2024-06-21
- at Aerovate Therapeutics Inc. (AVTE), 2024-06-20
- at Nkarta Inc. (NKTX), 2024-06-14
- at Acumen Pharmaceuticals Inc. (ABOS), 2024-06-10
- at Mineralys Therapeutics Inc. (MLYS), 2024-05-28
- at Vor Biopharma Inc. (VOR), 2024-05-28
- at Werewolf Therapeutics Inc. (HOWL), 2024-05-24
- at Iteos Therapeutics Inc. (ITOS), 2024-05-15
- at Boundless Bio Inc. (BOLD), 2024-04-04
- at Lenz Therapeutics Inc. (LENZ), 2024-03-26
- at Icosavax Inc. (ICVX), 2024-02-21
- Large Shareholder, Director at Solid Biosciences Inc. (SLDB), 2024-01-12
- Other at Dice Therapeutics Inc. (DICE), 2023-08-09
- Director at Black Diamond Therapeutics Inc. (BDTX), 2023-07-07
- Other at Satsuma Pharmaceuticals Inc. (STSA), 2023-06-13
- Other at Enliven Therapeutics Inc. (ELVN), 2023-02-27
- Large Shareholder, Director at Forma Therapeutics Holdings Inc. (FMTX), 2022-10-14
- Large Shareholder at Kala Pharmaceuticals Inc. (KALA), 2022-05-26
- Large Shareholder, Director at Cytek Biosciences Inc. (CTKB), 2022-03-16
- Large Shareholder at Rxsight Inc. (RXST), 2021-08-13
- Director at Therapeutics Acquisition Corp. (RACA), 2021-06-24
- Large Shareholder at Scpharmaceuticals Inc. (SCPH), 2021-03-16
- Large Shareholder at Phathom Pharmaceuticals Inc. (PHAT), 2021-03-15
- Large Shareholder, Director at Orchard Therapeutics Plc (ORTX), 2021-02-11
- Large Shareholder at Iterum Therapeutics Plc (ITRM), 2021-02-08
- Large Shareholder at Miragen Therapeutics Inc. (MGEN), 2020-12-17
- Other at Rhythm Pharmaceuticals Inc. (RYTM), 2020-12-04
- Large Shareholder at Vaxcyte Inc. (PCVX), 2020-10-09
- Large Shareholder at Cardiff Oncology Inc. (CRDF), 2020-10-02
- Large Shareholder at Pmv Pharmaceuticals Inc. (PMVP), 2020-09-29
- Large Shareholder at Dyne Therapeutics Inc. (DYN), 2020-09-23
- Large Shareholder at Tg Therapeutics Inc. (TGTX), 2020-09-11
- Large Shareholder at Inhibrx Inc. (INBX), 2020-08-24
- Large Shareholder at Inozyme Pharma Inc. (INZY), 2020-07-28
- Large Shareholder at Pandion Therapeutics Inc. (PAND), 2020-07-22
- Large Shareholder at Akouos Inc. (AKUS), 2020-07-02
- Large Shareholder at Verastem Inc. (VSTM), 2020-06-29
- Large Shareholder, Director at Ra Pharmaceuticals Inc. (RARX), 2020-04-03
- Large Shareholder at Synthorx Inc. (THOR), 2020-01-24
- Large Shareholder at Eiger Biopharmaceuticals Inc. (EIGR), 2018-10-25
- Other at Arvinas Inc. (ARVN), 2018-10-03
- Director at Eidos Therapeutics Inc. (EIDX), 2018-06-22
- Large Shareholder at Dicerna Pharmaceuticals Inc (DRNA), 2017-12-21
- Large Shareholder, Director at Kalvista Pharmaceuticals Inc. (KALV), 2017-10-16
- Other at G1 Therapeutics Inc. (GTHX), 2017-05-24
- Large Shareholder at Aclaris Therapeutics Inc. (ACRS), 2016-09-19
- Other at Sangamo Biosciences Inc (SGMO), 2015-02-19
- Other at Achillion Pharmaceuticals Inc (ACHN), 2015-01-20
- Other at Derma Sciences Inc. (DSCI), 2014-01-13
- Large Shareholder at Biospecifics Technologies Corp (BSTC), 2010-02-26
Insider Trading: Purchases See All
Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|---|
TYRA | $16.25 | 1,220,681 | 8,697,956 | 2024-11-08 | Filing | ||
SEPN | $18.00 | 341,600 | 1,471,943 | 2024-10-28 | Filing | ||
SEPN | $18.00 | 3,828,400 | 5,523,915 | 2024-10-28 | Filing | ||
JANX | $44.75 | 1,200,000 | 9,317,246 | 2024-10-18 | Filing | ||
BCAX | $18.00 | 152,480 | 2,652,575 | 2024-09-16 | Filing |
Insider Trading: Sales See All
Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|---|
ANTX | $1.08 | 114,759 | 300,853 | 2024-08-09 | Filing | ||
ANTX | $1.08 | 3,410,335 | 1,725,348 | 2024-08-09 | Filing | ||
KALA | $0.36 | 1,005,686 | Large Shareholder | 7,039,613 | 2022-05-26 | Filing | |
KALA | $0.42 | 1,434,509 | Large Shareholder | 8,045,299 | 2022-05-25 | Filing | |
KALA | $0.51 | 144,805 | Large Shareholder | 9,479,808 | 2022-05-24 | Filing |